- Report
- February 2023
- 220 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2019
- 35 Pages
Global
From €960EUR$1,000USD£827GBP
Atacand is a cardiovascular drug used to treat hypertension, congestive heart failure, and coronary artery disease. It is an angiotensin II receptor antagonist, which works by blocking the action of a hormone that causes blood vessels to constrict. This helps to reduce blood pressure and improve blood flow. Atacand is also used to reduce the risk of stroke in people with high blood pressure and an enlarged heart.
Atacand is available in both generic and brand-name forms. It is typically taken once daily, with or without food. Common side effects include dizziness, headache, and fatigue.
The Atacand market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include AstraZeneca, Teva Pharmaceuticals, Mylan, and Sandoz. Other companies include Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Lupin Pharmaceuticals. Show Less Read more